Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Peter Pickkers and Tim Frenzel.
Peter Pickkers
Connection Strength
0.469
Tim Frenzel
  1. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care. 2021 08 05; 25(1):281.
    View in: PubMed
    Score: 0.240
  2. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
    View in: PubMed
    Score: 0.059
  3. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals. Int J Antimicrob Agents. 2021 Mar; 57(3):106293.
    View in: PubMed
    Score: 0.058
  4. Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times? Crit Care. 2020 10 06; 24(1):600.
    View in: PubMed
    Score: 0.057
  5. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients. Crit Care. 2020 May 26; 24(1):263.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.